文献速递免疫规划

8-12月龄婴儿Edmonston-Zagreb株与AIK-C株麻疹疫苗免疫原性头对头比较:一项随机临床试验

Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial.
PubMed 文献 · Vaccine · 2017-12-27

在伊朗锡斯坦-俾路支斯坦省扎黑丹地区开展多中心平行随机双盲非劣效试验,200名8-12月龄婴儿随机接种含Edmonston-Zagreb(EZ)株或AIK-C株的麻疹-风疹疫苗。P=.012)。

要点

  • EZ组血清阳转率76.1%(95%CI:60.2-85.2%)vs AIK-C组58.7%(95%CI:48.8-68.7%)。
  • 研究期间未报告不良事件。

核心结论

  • 在生命第一年可观察到含不同麻疹疫苗株疫苗的血清阳性率存在相当差异。

研究设计与样本

  • 在伊朗锡斯坦-俾路支斯坦省扎黑丹地区实施的多中心平行随机双盲非劣效试验,比较EZ株与AIK-C株麻疹疫苗。
  • 200名8-12月龄、父母知情同意的婴儿按4-8的置换区组随机分配至四家城市卫生诊所。
  • 接种前采血后接种含相应疫苗株的麻疹-风疹疫苗,60天后采集第二份血样,血清在国家麻疹参比实验室检测抗麻疹抗体。
  • 父母、实验室技术人员和统计人员对分组设盲。

主要发现

  • 200名儿童等量随机分入两臂,185名接种前血清阴性者(EZ组88名、AIK-C组97名)进入最终分析。
  • EZ组血清阳转率为76.1%(95%CI:60.2-85.2%),AIK-C组为58.7%(95%CI:48.8-68.7%)。
  • 研究期间未报告不良事件。

关键数值与推荐

  • EZ组血清阳转率76.1%(95%CI:60.2-85.2%)vs AIK-C组58.7%(95%CI:48.8-68.7%)。
  • EZ相对AIK-C血清阳转率1.3(95%CI:1.1-1.6;P=.012)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A non-inferiority multi-centre parallel randomized double-blind trial was implemented in Zahedan district, Sistan-va-Baluchestan province, Iran, to compare the performance of the two measles vaccines which are in use in the National Immunization Programme of Iran and are of two different measles virus vaccine strains: Edmonston-Zagreb (EZ) strain vs. AIK-C strain. The main outcome measure was appearance of anti-measles antibody in sera. METHODS: 200 infants, 8-12 months old, whose parents consented for their children to be included in the study, were randomized in permutation blocks of size 4-8 in four Urban Health Clinics. Having given a pre-vaccination blood sample, they received measles-rubella vaccine containing one of the vaccine strains mentioned before. After 60 days, the second blood sample was taken. The sera of the pre- and post-vaccination blood samples were tested for anti-measles antibodies in the National Reference Measles Laboratory. Parents, laboratory technicians and statistician were blind to groupings. RESULTS: Of the 200 children equally randomized in the two arms, 185 who were seronegative before vaccination (88 in the EZ arm and 97 in the AIK-C arm) were entered in the final analysis. The seroconversion rate in the EZ arm was 76.1% (95% CI: 60.2-85.2%), and that in the AIK-C arm was 58.7%; (95% CI: 48.8-68.7%). The absolute rate difference was 17. 4% (4.1-30.9%; P-value: .012), and the relative seroconversion rate of EZ to AIK-C was 1.3 (95% CI: 1.1-1.6; P-value: .012). No adverse events were reported during the study period. CONCLUSION: A considerable difference in the seropositivity of different measles containing vaccines could be demonstrated in the first year of life. TRIAL REGISTRATION: Iranian Registry of Clinical Trials Registration Number: IRCT2016032827144N1; May 10, 2016 (www.who.int/ictrp/network/irct/en/).

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Izadi S, Zahraei SM, Salehi M, et al. Head-to-head immunogenicity comparison of Edmonston-Zagreb vs. AIK-C measles vaccine strains in infants aged 8-12 months: A randomized clinical trial. Vaccine. 2017. PMID: 29289382. doi:10.1016/j.vaccine.2017.12.048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。